Misoprostol administered by epithelial routes: Drug absorption and uterine response
- PMID: 16946218
- DOI: 10.1097/01.AOG.0000230398.32794.9d
Misoprostol administered by epithelial routes: Drug absorption and uterine response
Abstract
Objective: To quantify and compare serum levels and uterine effects following vaginal (dry), vaginal (moistened), buccal, and rectal misoprostol administration.
Methods: Forty women seeking elective abortion between 6 and 12 6/7 weeks were randomly assigned to receive 400 mug of misoprostol by one of four routes. A 2.5-mm pressure monitoring catheter was placed through the cervix to the uterine fundus to record uterine tone and activity during the 5-hour observation period. Serum levels of misoprostol acid were measured at 15 and 30 minutes, then every 30 minutes.
Results: The four groups were similar in age, race or ethnicity, body mass index, parity, and gestation. Serum levels after vaginal, vaginal moistened and buccal administration rose gradually, peaked between 15 and 120 minutes and fell slowly. Vaginal and vaginal moistened routes produced higher peak serum levels than buccal and rectal (445.9 and 427.1 compared with 264.8 and 202.2 pg/mL; P = .03) and higher serum concentration area under the curve at 5 hours (1,025.0 and 1279.4 compared with 519.6 and 312.5 pg-hr/mL; P < .001). Uterine tone and activity, however, were similar for buccal and the two vaginal routes. After rectal administration, serum levels peaked earlier (P < .001) then dropped more abruptly, and peak uterine tone (P < .001) and total activity (P = .04) were lower than after the other routes.
Conclusion: Although serum levels were lower for buccal compared with the vaginal routes, the three routes produced similar uterine tone and activity. Rectal administration produced lower uterine tone and activity. Vaginal serum levels were two to three and a half times higher than those observed in prior misoprostol pharmacokinetic studies.
Similar articles
-
Absorption kinetics of misoprostol with oral or vaginal administration.Obstet Gynecol. 1997 Jul;90(1):88-92. doi: 10.1016/S0029-7844(97)00111-7. Obstet Gynecol. 1997. PMID: 9207820 Clinical Trial.
-
Comparison of misoprostol plasma concentrations following buccal and sublingual administration.Contraception. 2005 Jan;71(1):22-5. doi: 10.1016/j.contraception.2004.06.014. Contraception. 2005. PMID: 15639067 Clinical Trial.
-
Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.Contraception. 2004 Dec;70(6):463-6. doi: 10.1016/j.contraception.2004.05.003. Contraception. 2004. PMID: 15541407 Clinical Trial.
-
The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.Contraception. 2006 Jul;74(1):26-30. doi: 10.1016/j.contraception.2006.03.005. Epub 2006 Apr 27. Contraception. 2006. PMID: 16781256 Review.
-
Studies on uterine contractility following mifepristone and various routes of misoprostol.Contraception. 2006 Jul;74(1):31-5. doi: 10.1016/j.contraception.2006.03.009. Epub 2006 Apr 27. Contraception. 2006. PMID: 16781257 Review.
Cited by
-
Pharmacokinetics of vaginal versus buccal misoprostol for labor induction at term.Clin Transl Sci. 2022 Aug;15(8):1937-1945. doi: 10.1111/cts.13306. Epub 2022 Jun 12. Clin Transl Sci. 2022. PMID: 35587540 Free PMC article. Clinical Trial.
-
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.N Engl J Med. 2018 Jun 7;378(23):2161-2170. doi: 10.1056/NEJMoa1715726. N Engl J Med. 2018. PMID: 29874535 Free PMC article. Clinical Trial.
-
Preoperative versus postoperative misoprostol use for prevention of blood loss during caesarean section in pregnant women at term: a multi-centre randomised controlled trial.J Int Med Res. 2023 Nov;51(11):3000605231213242. doi: 10.1177/03000605231213242. J Int Med Res. 2023. PMID: 37994048 Free PMC article. Clinical Trial.
-
Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis.Contracept X. 2020 Aug 20;2:100037. doi: 10.1016/j.conx.2020.100037. eCollection 2020. Contracept X. 2020. PMID: 32954250 Free PMC article. Review.
-
A randomized controlled trial of misoprostol and sulprostone to end pregnancy after fetal death.Obstet Gynecol Int. 2009;2009:496320. doi: 10.1155/2009/496320. Epub 2009 Sep 6. Obstet Gynecol Int. 2009. PMID: 19960062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical